Human Longevity, Inc. — Form D
Human Longevity, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-07. The offering totals $22.5M, of which $10.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-04-07
- Form: D
- Accession: 0001781303-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $22.5M
- Amount sold: $10.5M
- Remaining: $12.0M
- Investors: 4
- Date of first sale: 2023-03-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-478201
Issuer
- Name: Human Longevity, Inc.
- CIK: 0001781303
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4570 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
- Phone: 844-838-3322
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Helmut Schuehsler | Director | Singapore, U0 |
| Wei-Wu He | Director | Rockville, MD |
| James Huang | Director | South San Francisco, CA |
| David Karow | Director | San Diego, CA |
| David Karow | Executive Officer | San Diego, CA |
| James Hu | Director | Rockville, MD |
| James Hu | Executive Officer | Rockville, MD |
Other filings by this issuer (3)
More